Deubiquitination of EGFR by Cezanne-1 contributes to cancer progression

Oncogene

Volumn 31, Issue 43, 2012, Pages 4599-4608

  Pareja, F ^a   Ferraro, D A ^a   Rubin, C ^a   Cohen Dvashi, H ^a   Zhang, F ^b   Aulmann, S ^c   Ben Chetrit, N ^a   Pines, G ^a   Navon, R ^d   Crosetto, N ^e   Kostler W ^a   Carvalho, S ^a,f   Lavi, S ^a   Schmitt, F ^f   Dikic, I ^e   Yakhini, Z ^d,g   Sinn, P ^c   Mills, G B ^b   Yarden, Y ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d Agilent Laboratories   (Israel)

^e GOETHE UNIVERSITY   (Germany)

^f University of Porto   (Portugal)

^g TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

deubiquitination; endocytosis; gene amplification; growth factor

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN CEZANNE 1; PROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER GROWTH; CELL MIGRATION; CONTROLLED STUDY; DISEASE COURSE; ENZYME SUBSTRATE COMPLEX; GENE AMPLIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRACELLULAR SIGNALING; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DEUBIQUITINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE;

CATALYSIS; DISEASE PROGRESSION; ENDOPEPTIDASES; HUMANS; NEOPLASMS; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, SMALL INTERFERING; UBIQUITIN; UBIQUITINATION;

EID: 84867900349     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.587     Document Type: Article

References (40)

1. Avraham R, Yarden Y. Feedback regulation of EGFR signalling: decision making by early and delayed loops. Nat Rev Mol Cell Biol 2010; 12: 104-117.
2. Sorkin A, von Zastrow M. Endocytosis and signalling: intertwining molecular networks. Nat Rev Mol Cell Biol 2009; 10: 609-622.
3. Goh LK, Huang F, Kim W, Gygi S, Sorkin A. Multiple mechanisms collectively regulate clathrin-mediated endocytosis of the epidermal growth factor receptor. J Cell Biol 2010; 189: 871-883.
4. Fehrenbacher N, Bar-Sagi D, Philips M. Ras/MAPK signaling from endomembranes. Mol Oncol 2009; 3: 297-307.
5. Vieira AV, Lamaze C, Schmid SL. Control of EGF receptor signaling by clathrinmediated endocytosis. Science 1996; 274: 2086-2089. (Pubitemid 27020702)
6. Frosi Y, Anastasi S, Ballaro C, Varsano G, Castellani L, Maspero E et al. A two-tiered mechanism of EGFR inhibition by RALT/MIG6 via kinase suppression and receptor degradation. J Cell Biol 2010; 189: 557-571.
7. Huang F, Kirkpatrick D, Jiang X, Gygi S, Sorkin A. Differential regulation of EGF receptor internalization and degradation by multiubiquitination within the kinase domain. Mol Cell 2006; 21: 737-748. (Pubitemid 43376125)
8. Levkowitz G, Waterman H, Ettenberg SA, Katz M, Tsygankov AY, Alroy I et al. Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1. Mol Cell 1999; 4: 1029-1040. (Pubitemid 30054908)
9. Mosesson Y, Shtiegman K, Katz M, Zwang Y, Vereb G, Szollosi J et al. Endocytosis of receptor tyrosine kinases is driven by monoubiquitylation, not polyubiquitylation. J Biol Chem 2003; 278: 21323-21326. (Pubitemid 36792525)
10. Haglund K, Sigismund S, Polo S, Szymkiewicz I, Di Fiore PP, Dikic I. Multiple monoubiquitination of RTKs is sufficient for their endocytosis and degradation. Nat Cell Biol 2003; 5: 461-466. (Pubitemid 36592270)
11. Katzmann DJ, Odorizzi G, Emr SD. Receptor downregulation and multivesicularbody sorting. Nat Rev Mol Cell Biol 2002; 3: 893-905.
12. Polo S, Sigismund S, Faretta M, Guidi M, Capua MR, Bossi G et al. A single motif responsible for ubiquitin recognition and monoubiquitination in endocytic proteins. Nature 2002; 416: 451-455. (Pubitemid 34272882)
13. Katz M, Shtiegman K, Tal-Or P, Yakir L, Mosesson Y, Harari D et al. Ligandindependent degradation of epidermal growth factor receptor involves receptor ubiquitylation and Hgs, an adaptor whose ubiquitin-interacting motif targets ubiquitylation by Nedd4. Traffic 2002; 3: 740-751.
14. Sacco JJ, Coulson JM, Clague MJ, Urbe S. Emerging roles of deubiquitinases in cancer-associated pathways. IUBMB Life 2010; 62: 140-157.
15. Bowers K, Piper SC, Edeling MA, Gray SR, Owen DJ, Lehner PJ et al. Degradation of endocytosed epidermal growth factor and virally ubiquitinated major histocompatibility complex class I is independent of mammalian ESCRTII. J Biol Chem 2006; 281: 5094-5105. (Pubitemid 43847775)
16. McCullough J, Clague MJ, Urbe S. AMSH is an endosome-associated ubiquitin isopeptidase. J Cell Biol 2004; 166: 487-492. (Pubitemid 39097168)
17. Nakamura M, Tanaka N, Kitamura N, Komada M. Clathrin anchors deubiquitinating enzymes, AMSH and AMSH-like protein, on early endosomes. Genes Cells 2006; 11: 593-606. (Pubitemid 43744810)
18. Ma YM, Boucrot E, Villen J, Affar el B, Gygi SP, Gottlinger HG et al. Targeting of AMSH to endosomes is required for epidermal growth factor receptor degradation. J Biol Chem 2007; 282: 9805-9812. (Pubitemid 47104609)
19. Row PE, Prior IA, McCullough J, Clague MJ, Urbe S. The ubiquitin isopeptidase UBPY regulates endosomal ubiquitin dynamics and is essential for receptor downregulation. J Biol Chem 2006; 281: 12618-12624. (Pubitemid 43855351)
20. Duex JE, Sorkin A. RNA interference screen identifies Usp18 as a regulator of epidermal growth factor receptor synthesis. Mol Biol Cell 2009; 20: 1833-1844.
21. Enesa K, Zakkar M, Chaudhury H, Luong le A, Rawlinson L, Mason JC et al. NF-kappaB suppression by the deubiquitinating enzyme Cezanne: a novel negative feedback loop in pro-inflammatory signaling. J Biol Chem 2008; 283: 7036-7045.
22. Evans PC, Smith TS, Lai MJ, Williams MG, Burke DF, Heyninck K et al. A novel type of deubiquitinating enzyme. J Biol Chem 2003; 278: 23180-23186. (Pubitemid 36830384)
23. Lee S, Tsai YC, Mattera R, Smith WJ, Kostelansky MS, Weissman AM et al. Structural basis for ubiquitin recognition and autoubiquitination by Rabex-5. Nat Struct Mol Biol 2006; 13: 264-271. (Pubitemid 43348513)
24. Penengo L, Mapelli M, Murachelli AG, Confalonieri S, Magri L, Musacchio A et al. Crystal structure of the ubiquitin binding domains of rabex-5 reveals two modes of interaction with ubiquitin. Cell 2006; 124: 1183-1195.
25. Crosetto N, Bienko M, Hibbert RG, Perica T, Ambrogio C, Kensche T et al. Human Wrnip1 is localized in replication factories in a ubiquitin-binding zinc fingerdependent manner. J Biol Chem 2008; 283: 35173-35185.
26. Dikic I, Wakatsuki S, Walters KJ. Ubiquitin-binding domains-from structures to functions. Nat Rev Mol Cell Biol 2009; 10: 659-671.
27. Magnifico A, Ettenberg S, Yang C, Mariano J, Tiwari S, Fang S et al. WW domain HECT E3s target Cbl RING finger E3s for proteasomal degradation. J Biol Chem 2003; 278: 43169-43177. (Pubitemid 37345936)
28. Courbard JR, Fiore F, Adelaide J, Borg JP, Birnbaum D, Ollendorff V. Interaction between two ubiquitin-protein isopeptide ligases of different classes, CBLC and AIP4/ITCH. J Biol Chem 2002; 277: 45267-45275. (Pubitemid 36159132)
29. Sowa ME, Bennett EJ, Gygi SP, Harper JW. Defining the human deubiquitinating enzyme interaction landscape. Cell 2009; 138: 389-403.
30. Courjal F, Theillet C. Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification. Cancer Res 1997; 57: 4368-4377. (Pubitemid 27413448)
31. Hawthorn L, Luce J, Stein L, Rothschild J. Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast. BMC Cancer 2010; 10: 460.
32. Orsetti B, Nugoli M, Cervera N, Lasorsa L, Chuchana P, Rouge C et al. Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q. Br J Cancer 2006; 95: 1439-1447. (Pubitemid 44760099)
33. Tarcic G, Boguslavsky SK, Wakim J, Kiuchi T, Liu A, Reinitz F et al. An unbiased screen identifies DEP-1 tumor suppressor as a phosphatase controlling EGFR endocytosis. Curr Biol 2009; 19: 1788-1798.
34. Wertz IE, O'Rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S et al. Deubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 2004; 430: 694-699. (Pubitemid 39061687)
35. Mills GB, Jurisica I, Yarden Y, Norman JC. Genomic amplicons target vesicle recycling in breast cancer. J Clin Invest 2009; 119: 2123-2127.
36. Zhang J, Liu X, Datta A, Govindarajan K, Tam WL, Han J et al. RCP is a human breast cancer-promoting gene with Ras-activating function. J Clin Invest 2009; 119: 2171-2183.
37. Hou Q, Wu YH, Grabsch H, Zhu Y, Leong SH, Ganesan K et al. Integrative genomics identifies RAB23 as an invasion mediator gene in diffuse-type gastric cancer. Cancer Res 2008; 68: 4623-4630.
38. Cheng KW, Lahad JP, Kuo WL, Lapuk A, Yamada K, Auersperg N et al. The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers. Nat Med 2004; 10: 1251-1256. (Pubitemid 39540444)
39. Palmieri D, Bouadis A, Ronchetti R, Merino MJ, Steeg PS. Rab11a differentially modulates epidermal growth factor-induced proliferation and motility in immortal breast cells. Breast Cancer Res Treat 2006; 100: 127-137. (Pubitemid 44631914)
40. Caswell PT, Chan M, Lindsay AJ, McCaffrey MW, Boettiger D, Norman JC. Rab-coupling protein coordinates recycling of alpha5beta1 integrin and EGFR1 to promote cell migration in 3D microenvironments. J Cell Biol 2008; 183: 143-155.